Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced that executive management will participate in three upcoming conferenceMr. Christensen will also present at the Cowen and Company 31st Annual Health Care Conference, on Tuesday, March 8 at 11:00 AM (ET). The conference is being held March 7-9, at the Boston Marriott Copley Place in Boston, MA.

B&G Foods, Inc. (NYSE:BGS) and its subsidiaries manufacture, sell and distribute a diversified portfolio of high-quality, shelf-stable foods across the United States, Canada and Puerto Rico.

Given Imaging Ltd. (Nasdaq:GIVN) announced that the U.S. Food and Drug Administration (FDA) has cleared revised labeling regarding the use of the SensorBelt in patients with a Body Mass Index (BMI) of up to 43.3 kg/m2, reflecting the results of a recent clinical trial.